|
Real-time Estimate
Cboe BZX
17:22:43 30/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 6.290 USD | +0.48% |
|
-3.38% | -38.91% |
| Market Cap | 226M 199M 188M 171M 320M 21.66B 324M 2.26B 871M 11.06B 848M 829M 35.59B | P/E 2026 * |
-1.56x | P/E 2027 * | -1.73x |
|---|---|---|---|---|---|
| Enterprise Value | 196M 173M 163M 148M 278M 18.77B 280M 1.96B 755M 9.58B 734M 718M 30.84B | EV / Sales 2026 * |
16.1x | EV / Sales 2027 * | -2.33x |
| Free-Float |
85.81% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TRDA | Delayed | |
CBOE
| TRDA | Real-time |
Last Transcript: Entrada Therapeutics, Inc.
| 20/12/22 | Nipte winst op Wall Street | |
| 20/12/22 | Wall Street licht hoger | |
| 20/12/22 | Wall Street richting rode opening |
| 1 day | +0.32% | ||
| 1 week | -3.38% | ||
| Current month | -10.92% | ||
| 1 month | -10.92% | ||
| 3 months | -14.67% | ||
| 6 months | -46.64% | ||
| Current year | -38.91% |
| 1 week | 5.92 |  | 6.47 |
| 1 month | 5.92 | | 7.7 |
| Current year | 5.63 | | 16.45 |
| 1 year | 5.55 | | 16.45 |
| 3 years | 4.93 | | 21.79 |
| 5 years | 4.93 | | 36.85 |
| 10 years | 4.93 | | 36.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dipal Doshi
CEO | Chief Executive Officer | 50 | 31/07/2017 |
Kory Wentworth
DFI | Director of Finance/CFO | 47 | 31/10/2020 |
Nathan Dowden
PSD | President | 56 | 31/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Dipal Doshi
BRD | Director/Board Member | 50 | 31/07/2017 |
Kush Parmar
CHM | Chairman | 45 | 30/11/2020 |
Peter Kim
BRD | Director/Board Member | 67 | 30/11/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 09/09/26 | MPM BioImpact LLC
| Sell | Company | -28,837 | 0.0741% | |
| 09/09/26 | MPM BioImpact LLC
| Sell | Company | -28,837 | 0.0741% | |
| 03/09/26 | MPM BioImpact LLC
| Sell | Company | -32,263 | 0.0829% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.48% | -3.38% | +8.28% | -57.71% | 226M | |
| +4.16% | -0.30% | +58.96% | +94.17% | 71.53B | |
| -0.19% | +1.32% | +37.20% | +81.33% | 60.12B | |
| -1.51% | +2.39% | +9.10% | +36.79% | 48.85B | |
| +0.76% | +1.56% | +43.22% | +40.31% | 44.28B | |
| +1.37% | +9.36% | +346.66% | +697.06% | 43.83B | |
| +2.11% | +2.36% | +9.66% | +109.31% | 41.53B | |
| -0.67% | -0.45% | +4.47% | +46.37% | 30.13B | |
| +4.77% | +6.46% | +41.54% | +22.78% | 27.98B | |
| -0.03% | -2.09% | -19.54% | +356.70% | 25.25B | |
| Average | +1.14% | -0.24% | +53.95% | +142.71% | 39.37B | |
| Weighted average by Cap. | +1.32% | +0.62% | +64.03% | +155.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 12.17M 10.74M 10.16M 9.21M 17.27M 1.17B 17.44M 122M 46.97M 596M 45.68M 44.69M 1.92B | 22.86M 20.17M 19.09M 17.31M 32.45M 2.19B 32.77M 229M 88.25M 1.12B 85.84M 83.97M 3.6B |
| Net income | -174M -154M -146M -132M -248M -16.73B -250M -1.75B -673M -8.54B -655M -640M -27.49B | -184M -163M -154M -140M -262M -17.7B -264M -1.85B -712M -9.04B -693M -677M -29.08B |
| Net Debt | -30.12M -26.58M -25.15M -22.81M -42.77M -2.89B -43.19M -302M -116M -1.48B -113M -111M -4.75B | -279M -246M -233M -211M -396M -26.78B -400M -2.8B -1.08B -13.67B -1.05B -1.03B -44.01B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/09/26 | US$6.280 | +0.32% | 38,110 |
| 29/09/26 | US$6.260 | +0.64% | 268,586 |
| 28/09/26 | US$6.220 | +0.97% | 442,585 |
| 25/09/26 | US$6.160 | -0.96% | 374,038 |
| 24/09/26 | US$6.220 | -4.31% | 319,117 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TRDA Stock
Select your edition
All financial news and data tailored to specific country editions
